Co-Expression of CD133+/CD44+in Human Colon Cancer and Liver Metastasis

Journal of Cellular Physiology - United States
doi 10.1002/jcp.24145
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Co-Expression and Prognostic Significance of Putative CSC Markers CD44, CD133, Wild-Type EGFR and EGFRvIII in Metastatic Colorectal Cancer

Oncotarget
Oncology
2019English

Co-Expression of CD133, CD44v6 and Human Tissue Factor Is Associated With Metastasis and Poor Prognosis in Pancreatic Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2014English

Loss of Smad4 Expression Predicts Liver Metastasis in Human Colorectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2007English

Inhibition of the Growth and Metastasis of Human Colon Cancer by Restoration of RUNX3 Expression in Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
1992English

Evaluation of CD44 and CD133 as Cancer Stem Cell Markers for Colorectal Cancer

Oncology Reports
MedicineCancer ResearchOncology
2012English

Expression of CD133+ Cancer Stem Cells in Childhood Malignant Melanoma and Its Correlation With Metastasis

Modern Pathology
Forensic MedicinePathology
2010English

Characterization of the Conversion Between CD133+and CD133-cells in Colon Cancer SW620 Cell Line

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2012English

Establishment of a New Human Colon Cancer Cell Line (OCUC-LM 1) and Experimental Liver Metastasis Model.

Nippon Daicho Komonbyo Gakkai Zasshi
1994English

Butyrate Down-Regulates CD44 Transcription and Liver Colonisation in a Highly Metastatic Human Colon Carcinoma Cell Line

British Journal of Cancer
Cancer ResearchOncology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy